On November 16 we convened a Front-of-Package Nutrition Labeling virtual public meeting that included opportunity for stakeholder comment.
Public Meeting: In-person and Virtual
October 4, 2023 | 9:15 am-5 pm (eastern)
The Foundation partnered with the Food and Drug Administration (FDA) to host "Mitigating Risks from Human Xylazine Exposure," a day-long meeting with both in-person and virtual attendance.
On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features. We convened international experts in the conduct of clinical trials with pragmatic or decentralized features.
